Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Haixia Chen
 + 2882 word(s) 2882 2022-01-19 04:36:04 |
2 format correct
Catherine Yang
 Meta information modification 2882 2022-03-07 02:41:17 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Chen, H. Orthosiphon stamineus Benth.. Encyclopedia. Available online: https://encyclopedia.pub/entry/20246 (accessed on 16 November 2024).
Chen H. Orthosiphon stamineus Benth.. Encyclopedia. Available at: https://encyclopedia.pub/entry/20246. Accessed November 16, 2024.
Chen, Haixia. "Orthosiphon stamineus Benth." Encyclopedia, https://encyclopedia.pub/entry/20246 (accessed November 16, 2024).
Chen, H. (2022, March 06). Orthosiphon stamineus Benth.. In Encyclopedia. https://encyclopedia.pub/entry/20246
Chen, Haixia. "Orthosiphon stamineus Benth.." Encyclopedia. Web. 06 March, 2022.
Orthosiphon stamineus Benth.
Edit
This entry is adapted from the peer-reviewed paper 10.3390/molecules27020444

Orthosiphon stamineus Benth. is a traditional medicine used in the treatment of diabetes and chronic renal failure in southern China, Malaysia, and Thailand. 

Orthosiphon stamineus diabetes diabetic complications

1. Introduction

Orthosiphon stamineus Benth. (Lamiaceae) is a perennial herb [1][2]. O. stamineus is widely distributed in the tropical and subtropical regions [3], including southeast Asian countries (Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Philippines) [4][5], southern China [6], India [7], Australia [5], etc. In addition to Orthosiphon stamineus Benth., it also has other scientific names, Clerodendranthus spicatus (Thunb) c. y. wu and Orthosiphon aristatus (Blume) Miq. [8][9][10]. It is usually called “Shencha” in Chinese. It is also called Cat’s whiskers [11], Misai Kucing [12], Java tea [13], and kumis kucing [14] in some Southeast Asian countries.
O. stamineus is a popular Chinese folk medicine and also a traditional medicine of Dai nationality of Yunnan Province in China [15]. It has been used to treat diabetes and some kidney diseases with a long history. Modern pharmacological studies show that O. stamineus has many pharmacological activities, including antioxidant, anti-inflammatory, kidney protection, antibacterial, anti-tumor, immunoregulation, and especially effective antidiabetic activities. [15][16]. It has been used for the treatment of diabetes and chronic renal failure clinically. It is also reported to have good therapeutic effects on some diabetic complications, especially diabetic nephropathy [6]. Thus, it is worthy of study for the discovery for new antidiabetic drugs from O. stamineus.
Diabetes is a chronic metabolic diseases caused by deficiency in insulin secretion and insulin resistance [17]. In 2021, diabetic patients were estimated to be approximately 537 million all over the world [18]. This number is on the rise, the reasons for which are an aging population, obesity, and unhealthy diets [19]. Diabetes can be classified into two major types: Type I Diabetes Mellitus (T1DM) and Type II Diabetes Mellitus (T2DM). T1DM is caused by insulin deficiency. The islet β-cells are damaged, leading to an absolute deficiency of insulin secretion. Patients need long-term exogenous insulin injection. However, for T2DM patients, metabolic disorder results in lower insulin sensitivity, insulin resistance, and relative insulin deficiency [17][19][20][21]. DM can damage organs and tissues and result in many complications, such as diabetic nephropathy, diabetic retinopathy, diabetic foot, diabetic neuropathy, etc.
Diabetes is treated with oral hypoglycemic drugs and insulin injection to reduce blood glucose levels, improve insulin secretion, and enhance insulin sensitivity. Besides, there also are natural products used in the treatment of diabetes, especially with good hypoglycemic effects. In classical antidiabetic drugs, exenatide is from the venom of Gila monster and acarbose is produced from Actinoplanes sp. by the large-scale fermentation [22][23]. Besides, metformin is a natural product derivative that originated from herbal medicine Galega officinalis and its constituent galegine [24]. Many other natural products, such as curcumin, cinnamon, pumpkin, bitter melon, Lycium barbarum, Portulaca oleracea, Aloe vera, etc., have also been proven to have antidiabetic activities but without general clinical practice [20][21][25][26][27]. Orthosiphon stamineus also has potential against diabetes.

2. Mechanisms of O. stamineus in the Treatment of Diabetes

2.1. Antioxidant Activity

Hyperglycemia metabolism and excessive free fatty acids can lead to the production of lots of free radicals, such as reactive oxygen species (ROS) and reactive nitrogen species (RNS). These free radicals can cause oxidative stress, impair the structures and functions of islet β-cells, and cause insulin secretion deficiency. Besides, they can also lead to insulin resistance by affecting multiple insulin signaling pathways. The antioxidant activity of O. stamineus is related to protecting islet cells and reducing insulin resistance. Researchers have always tested antioxidant activity by 1,1-diphenyl-2-picrylhydrazyl radical 2,2-diphenyl-1-(2,4,6-trinitrophenyl)hydrazyl (DPPH) assay, ferric ion reducing antioxidant power (FRAP) assay, and 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulphonate) (ABTS) assay. The activity of superoxide dismutase (SOD) and the level of malondialdehyde (MDA) are also used to determine antioxidant activities. SOD can scavenge free radicals and MDA is the end product of lipid oxidation [28][29].
The antioxidant properties of the ethanol extracts of some genotypes ranged up to 15.55 μmol trolox equivalent (TE)/g dry weight (DW) in DPPH assay, and ranged up to 1.60 mmol TE/g DW in FRAP assay [30]. The half maximal inhibitory concentration (IC50) value of the 70% ethanol extract was 58.85 ± 7.11 μg/mL in DPPH assay, a little higher than 15.05 ± 2.03 μg/mL of the positive control, rosmarinic acid [31]. The concentration value for 50% of maximal effect (EC50) of methanol extract was 0.67 mg/mL in DPPH assay [32]. The IC50 values of 50% methanol extract of O. stamineus leaves were 0.145 ± 0.030, 1.143 ± 0.056, 0.192 ± 0.012, and 0.013 ± 0.001 mg/mL in DPPH, ABTS, iron chelating and FRAP assays, respectively, a little higher than the positive control, rutin and caffeic acid [33]. The EC50 values of O. stamineus aqueous extract were 53.51 and 284.9 μg/mL, respectively, in DPPH and ABTS assays, higher than the positive control, ascorbic acid [34]. The antioxidant capacities of aqueous extract were higher than 20 mg ascorbic acid equivalents (VCEAC)/100 mL in ABTS assays, and about 40 mg VCEAC/100 mL in FRAP assays [35]. The DPPH free radical-scavenging activities of aqueous, 50% methanol, methanol, 70% acetone, and chloroform extracts (0.05 mg/mL) were about 85%, 90%, 88%, 83% and 70%, respectively, higher than some positive controls [36].
From these studies, it could be seen that the aqueous extract, ethanol extract, 70% ethanol extract, methanol extract, 50% methanol extract, 70% acetone extract, and chloroform extract all had free radical-scavenging activities in different assays.
O. stamineus ethanol extract (200 and 400 mg/kg) enhanced SOD activity and reduced MDA level in the liver homogenate of the high-fat diet group. Thus, O. stamineus extract might counteract oxidative stress in the liver [37]. The 50% ethanol extracts of O. stamineus roots, stems, and leaves (50 μg/mL) scavenged intracellular ROS and significantly increased cell viability under oxidative stress in IPEC-J2 cells. They could also decrease the MDA level in jejunal homogenates compared to the high-fat group. The extracts of roots and leaves significantly increased the jejunal SOD activity of mice [38].

2.2. Anti-Inflammatory Activity

In the pathogenesis of diabetes, inflammatory factors, such as interleukin (IL)-1β, IL-8, tumor necrosis factor (TNF)-α, and induced nitric oxide synthase (iNOS), are important factors related to insulin sensitivity. They interfere with insulin signal transduction by participating in the insulin signaling pathway, leading to insulin resistance. They also possibly damage islet β-cells. In addition, inflammatory factors also interact with oxidative stress, further aggravating insulin resistance. Therefore, anti-inflammatory activity is essential to attenuate the inflammatory response, protect islet cells, and improve insulin resistance. It is always tested through the levels of inflammatory factors and the inhibition of nitric oxide (NO) production in cells [39][40].
The swelling in auricle was inhibited by the treatment of ethanol extract, ethyl acetate (EtOAc), and aqueous fractions in acute inflammatory mice induced by xylene. The inhibition ratios were 48.2%, 63.3%, and 46.0% at the dose of 200 mg/kg. Some compounds isolated from EtOAc fractions, orthosiphol M, orthosiphonone A, orthosiphol B, neoorthosiphol A, orthosiphol D, fragransin B1, sinensetin and 5, 6, 7, 4′-tetramethoxyflavone, also showed marked repression in the observed auricle swelling at the dose of 50 mg/kg. Besides, some of these compounds inhibited pro-inflammatory cytokines production in lipopolysaccharide (LPS)-induced HK-2 cells, such as the levels of TNF-α, IL-1β, and IL-8 [41]. The isolated compounds (clerodens A–D) were studied for anti-inflammatory activities on LPS-induced NO production in RAW264.7 macrophages. The results showed that clerodens A–D had inhibitory activities with IC50 values of 18.9 ± 1.2, 14.7 ± 0.48, 12.4 ± 1.5, and 6.8 ± 0.92 μmol/L, respectively, a little higher than the positive control aminoguanidine [16]. Neoorthosiphonone A, isolated from O. stamineus, showed obvious inhibitory activity on NO production in LPS-activated macrophage-like J774.1 cells with the IC50 value of 7.08 μmol/L, which was more potent than the positive control NG-monomethyl-L-arginine (L-NMMA) [42]. The isolated siphonols A–E also inhibited NO production in LPS-activated macrophage-like J774.1 cells [43].

2.3. Regulate Lipid Metabolism

Diabetic patients often have abnormal lipid metabolism. In the pathogenesis of diabetes, disorders in lipid metabolism increase the levels of free fatty acids and total triglycerides (TG), damaging islet β-cells and leading to insulin resistance in other tissue cells. Because of insulin resistance, the serum levels of TG, total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) increase, while the level of high-density lipoprotein cholesterol (HDL-C) decreases [44]. In addition, leptin and adiponectin, which are secreted from adipocytes, are also associated with insulin resistance. Leptin can antagonize insulin and produce insulin resistance, while adiponectin can improve insulin sensitivity by increasing fatty acid oxidation and glucose uptake in skeletal muscle cells [45][46].
The inhibitory effect of O. stamineus ethanol extract against pancreatic lipase in vitro was determined by using orlistat as the positive control. The IC50 value of the extract was 5.7 mg/mL, compared to the value of orlistat (0.1 mg/mL). In vivo study, the mice were fed on HFD. The ethanol extract reduced the serum levels of TG, TC, LDL-C, and lipase. It also decreased the leptin level and increased the adiponectin level. The extract also attenuated excessive accumulation of fat in liver tissues through histological examination. These results all showed that the extract might regulate lipid metabolisms in adipocytes, downregulate lipid accumulation in the liver [37]. The aqueous extract lowered TC level and increased the ghrelin level in diabetic rats [47]. The aqueous extract also lowered TG level and increased HDL-C level in diabetic rats [48]. 3-Hydroxybutyrate (3-HBT) and acetoacetate were the representative metabolites of fatty acid metabolism, so their levels might be related to the lipid metabolism in the liver. In 1H-NMR spectroscopic analysis of urine of Azam’ study, aqueous extract showed a remarkable drop in acetoacetate and 3-HBT levels. The reason for that might be that the extract inhibited the abnormal lipid and fatty acid metabolism and re-established energy metabolism [49].

2.4. Inhibit the Activities of α-Amylase and α-Glucosidase

α-Amylase and α-glucosidase are the two key enzymes in the digestion and absorption of carbohydrates in the body. α-Amylase breaks down long-chain carbohydrates, and α-glucosidase hydrolyzes glucoside bonds to release glucose. They are directly involved in the metabolism of starch and glycogen. Therefore, inhibiting the activities of α-amylase and α-glucosidase can reduce the release of glucose from carbohydrate hydrolysis, slow down the absorption of glucose in the small intestine, and effectively lower postprandial blood glucose level [28][50][51]. The inhibitory activities of these enzymes were always tested in vitro.
Rosmarinic acid and 2-caffeoyl-L-tartaric acid were two constituents isolated from O. stamineus. In a recent study, their inhibition ratios on α-glucosidase (0.5 U/mL) were 71.06 ± 1.82% and 69.85 ± 1.27%, respectively, both higher than that of positive control, acarbose, at concentration of 5 mg/mL. Molecular docking results showed that the binding energy of 2-caffeoyl-L-tartaric acid and α-glucosidase was −7.7 kcal/mol, and there were 3 hydrogen bonds between them. The binding energy of rosmarinic acid and α-glucosidase was −8.6 kcal/mol. In the conformation of α-glucosidase-rosmarinic acid complex, there were 6 hydrogen bonds [52]. The 95% EEF showed higher α-glucosidase (86 μg/mL) inhibitory activity (IC50 = 40 ± 0.73 μg/mL) than acarbose (IC50 = 250 ± 1.05 μg/mL) [53]. The ethanol extract (1000 μg/mL) of some genotypes of O. stamineus inhibited α-glucosidase up to 62.84% [30]. The ethanol extract at concentration of 50 μg/mL inhibited α-glucosidase (0.57 U/mL) at 40.74%, α-amylase (1.6 U/mL) at 81.48%, higher than acarbose[54]. The 50% ethanol extract and the isolated compound sinensetin both showed inhibitory activity on α-glucosidase and α-amylase. The IC50 values on α-glucosidase (1.0 U/mL) were 4.63 ± 0.413 and 0.66 ± 0.025 mg/mL, and on α-amylase (0.5 mg/mL) were 36.70 ± 0.546 and 1.13 ± 0.026 mg/mL, respectively. The IC50 values of acarbose on α-glucosidase and α-amylase were 1.93 ± 0.281 mg/mL and 4.89 ± 0.397 mg/mL, respectively [55].

2.5. Promote Insulin Secretion, Ameliorate Insulin Resistance, Enhance Insulin Sensitivity

Insulin is a hormone secreted by islet β-cells. It can control blood glucose level and regulate glucose and lipid metabolism. Insulin promotes glucose uptake and utilization in the liver, muscle, and adipose cells to reduce postprandial blood glucose level. However, these functions can be achieved only by combining with insulin receptors (IR). IRs are widely distributed in the body. Muscle, fat, and liver are all insulin target organs or tissues. Insulin resistance occurs when insulin receptors become less sensitive to insulin due to various factors [56]. Normally, glucose is transported and utilized mainly under the stimulation of insulin through a variety of insulin signaling pathways, such as the phosphoinositide 3-kinase/protein kinase B (PI3k/Akt) pathway. Insulin binds to IRs on the cell membrane, causing tyrosine phosphorylation of insulin receptor substrates (IRS), activating the PI3k/Akt signaling pathway and increasing glucose uptake. Any abnormality in insulin signaling pathway may lead to insulin resistance [57][58]. In addition, protein tyrosine phosphatase 1B (PTP1B) is also associated with insulin resistance. High PTP1B activity can lead to the dephosphorylation of IR and IRS tyrosine and weaken insulin signal transduction, leading to insulin resistance [59][60]. In some investigations, it has been proved that the extract of O. stamineus and its active components promoted insulin secretion, improved insulin resistance, and enhanced insulin sensitivity.
Inhibition of PTP1B activity might improve IR and IRS, leading to the improvement of insulin resistance and enhancement of insulin sensitivity. Hence, five diterpenes isolated from O. stamineus were tested for PTP1B inhibitory activity. The IC50 values of siphonol B, orthosiphols B, G, I, and N were 8.18 ± 0.41, 9.84 ± 0.33, 3.82 ± 0.20, 0.33 ± 0.07, and 1.60 ± 0.17 μmol/L, respectively, compared to the positive control, ursolic acid (3.42 ± 0.26 μmol/L). The inhibition types of these five diterpenes on PTP1B were mixed-competitive, non-competitive, non-competitive, competitive, and uncompetitive, respectively [61]. The hexane fraction of 70% ethanol extract slightly increased insulin secretion in both basal and glucose-stimulated states, and also elevated the mRNA expression of insulin and pancreatic duodenal homeobox-1 (PDX-1) in INS-1 cells under normal and high-glucose conditions. PDX-1 is an essential transcription factor for insulin gene expression. Its main functions are to promote the proliferation of islet β-cells, inhibit the apoptosis of islet β-cells, and regulate the transcription of insulin genes. The fraction also increased p-PI3K levels and Akt phosphorylation in INS-1 cells [62]. The ethanol extract reduced the levels of homeostasis model assessment of insulin resistance (HOMA-IR) index in HFD-induced rats [37].

2.6. Reduce the Absorption of Intestinal Glucose, Increase Glucose Uptake by Peripheral Cells

Hyperglycemia is a typical characteristic of diabetes. Carbohydrates are absorbed by intestinal epithelial cells in the form of glucose after digestion by enzymes. The uptake and utilization of glucose mainly exist in peripheral tissues or cells, such as liver, muscle, and adipose cells. Therefore, reducing the absorption of intestinal glucose and promoting glucose uptake by peripheral cells are very important to reduce blood glucose [63].
The sub-fraction 2 of chloroform extract significantly inhibited the glucose absorption from the small intestine at concentrations of 0.5, 1.0, and 2.0 mg/mL. Sub-fraction 2 (2.0 mg/mL) significantly increased the glucose uptake of hemi-diaphragms during the 90-min incubation period [64]. Some diterpenes in O. stamineus had 2-deoxy-2-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)-D-glucose (2-NBDG) uptake effect in 3T3-L1 adipocytes. 2-NBDG was always used as a substrate to evaluate the action of compounds as insulin mimickers. Siphonol B, orthosiphols B, G, I, and N stimulated glucose uptake at the concentration of 5 and 10 μmol/L [61]. The aqueous extract of O. stamineus significantly enhanced glucose uptake and glucose consumption in 3T3-L1 adipocytes [65]. The O. stamineus aqueous extract could increase the glucose uptake in cells by measuring the traces of radiolabelled glucose in 3T3-L1 adipocytes model [66].

2.7. Promote Glycolysis, Inhibit Gluconeogenesis

Gluconeogenesis and glycolysis are two metabolic mechanisms to ensure glucose homeostasis. Glycolysis is the process of breaking down glucose to produce pyruvate, which is one of the most important pathways of glucose metabolism in the body. Increasing the expression of glucokinase and pyruvate kinase can promote glycolysis and reduce blood glucose. Gluconeogenesis is the process of converting non-sugar substances into glucose. Liver is the main organ for gluconeogenesis. Both insulin and glucagon can regulate liver gluconeogenesis through different signaling pathways [67][68].
In 1H-NMR spectroscopic analysis of urine of diabetic rats, aqueous extract increased the levels of pyruvate, succinate, and citrate compared to the model group. Pyruvate is an end product of glycolysis, and it can enter tricarboxylic acid (TCA) cycle. High glucose level inhibits glycolytic enzymes and decreases the generation of pyruvate, thereby reducing the TCA cycle activity, and thus may contribute to mitochondrial dysfunction. Mitochondrial dysfunction may induce diabetes by affecting insulin secretion of islet β-cells and aggravating insulin resistance. Citrate and succinate are the TCA cycle intermediates. Thus, the increased levels of pyruvate, citrate, and succinate showed that the aqueous extract might reduce blood glucose level by increasing glycolysis and decreasing gluconeogenesis, and it might also modulate TCA cycle and improve mitochondrial dysfunction [49].

2.8. Increase the Level of GLP-1

GLP-1 is released from intestinal cells and maintains blood glucose homeostasis by increasing insulin secretion and inhibiting glucagon secretion [69]. The aqueous extract of O. stamineus (0.1 g/100 g of body weight) increased GLP-1 level in diabetic rats—non-pregnant or pregnant [47].

3. Mechanisms of O. stamineus in the Treatment of Diabetic Complications

Chronic hyperglycemia may cause damage to vessels and microvessels, and also damage tissues and organs in the body, leading to diabetic nephropathy, diabetic retinopathy, diabetic foot, diabetic peripheral neuropathy, and diabetic cardiovascular complications. These diabetic complications are related to oxidative stress, nonenzymatic glycation of protein, and inflammatory factors [70].
In addition to antioxidant and anti-inflammatory activity, O. stamineus also has anti-glycation effects. The glycation process is the formation of Amadori products at first through the chemical reactions between amino acid residues in proteins and reducing sugars. These products transform into advanced glycation end products (AGEs) by dehydration and rearrangement reactions. The accumulation of AGEs is toxic to cells and tissues, leading to diabetic complications. The aqueous extract of O. stamineus had inhibitory capacities (more than 70%) on the formation of AGEs in bovine serum albumin (BSA)-glucose system [35].
Diabetic nephropathy (DN) is one of the main complications of diabetes. It may lead to renal failure. The O. stamineus aqueous extract lowered the 24 h urine albumin excretion rate (UAER), glomerular filtration rate (GFR), the index of kidney weight to body weight and MDA level in kidney tissues of diabetic rats. It also improved the activity of SOD in renal tissues. Under a light microscope, O. stamineus obviously improved the lesions of renal tissues. The protective effect of O. stamineus on diabetic rats may be related to antioxidative activity, anti-inflammatory activity, and inhibition of the proliferation of mesangial cells [71].

References

  1. Shafaei, A.; Halim, N.H.A.; Zakaria, N.; Ismail, Z. Analysis of Free Amino Acids in Different Extracts of Orthosiphon stamineus Leaves by High-Performance Liquid Chromatography Combined with Solid-Phase Extraction. Pharmacogn. Mag. 2017, 13 (Suppl. S3), 385–391.
  2. Guan, S.C.; Fan, G.Y. Diterpenoids from Aerial Parts of Clerodendranthus spicatus and Their Cytotoxic Activity. Helv. Chim. Acta 2014, 97, 1708–1713.
  3. Zhou, H.C.; Yang, L.; Guo, R.Z.; Li, J. Phenolic acid derivatives with neuroprotective effect from the aqueous extract of Clerodendranthus spicatus. J. Asian Nat. Prod. Res. 2017, 19, 974–980.
  4. Gan, S.H.; Tham, T.C.; Ng, M.X.; Chua, L.S.; Aziz, R.; Baba, M.R.; Abdullah, L.C.; Ong, S.P.; Law, C.L. Study on retention of metabolites composition in misai kucing (Orthosiphon stamineus) by heat pump assisted solar drying. J. Food Processing Preserv. 2017, 41, e13262.
  5. Luo, Y.; Cheng, L.Z.; Luo, Q.; Yan, Y.M.; Wang, S.M.; Sun, Q.; Cheng, Y.X. New ursane-type triterpenoids from Clerodendranthus spicatus. Fitoterapia 2017, 119, 69–74.
  6. Sun, Z.; Zheng, Q.; Ma, G.; Zhang, X.; Yuan, J.; Wu, H.; Liu, H.; Yang, J.; Xu, X. Four new phenolic acids from Clerodendranthus spicatus. Phytochem. Lett. 2014, 8, 16–21.
  7. Robaina-Mesa, M.; López-Hernández, O.D.; Rodríguez-Chanfrau, J.E.; Nogueira-Mendoza, A. Spray dried aqueous extract of Orthosiphon aristatus Blume (Java tea). Braz. J. Pharm. Sci. 2017, 53, 1–5.
  8. Chung, Y.S.; Choo, B.K.M.; Ahmed, P.K.; Othman, I.; Shaikh, M.F. A Systematic Review of the Protective Actions of Cat’s Whiskers (Misai Kucing) on the Central Nervous System. Front. Pharm. 2020, 11, 692.
  9. Yuliana, N.D.; Khatib, A.; Link-Struensee, A.M.R.; Ijzerman, A.P.; Rungkat-Zakaria, F.; Choi, Y.H.; Verpoorte, R. Adenosine A(1) Receptor Binding Activity of Methoxy Flavonoids from Orthosiphon stamineus. Planta Med. 2009, 75, 132–136.
  10. Yoshimura, H.; Sugawara, K.; Saito, M.; Saito, S.; Murakami, S.; Miyata, N.; Kawashima, A.; Morimoto, S.; Gao, N.; Zhang, X.G.; et al. In vitro TGF-beta 1 antagonistic activity of ursolic and oleanolic acids isolated from Clerodendranthus spicatus. Planta Med. 2003, 69, 673–675.
  11. Hashim, S.; Beh, H.K.; Hamil, M.S.R.; Ismail, Z.; Majid, A. High-performance thin-layer chromatography method development, validation, and simultaneous quantification of four compounds identified in standardized extracts of Orthosiphon stamineus. Pharmacogn. Res. 2016, 8, 238–243.
  12. Saidan, N.H.; Aisha, A.F.; Hamil, M.S.; Majid, A.M.; Ismail, Z. A novel reverse phase high-performance liquid chromatography method for standardization of Orthosiphon stamineus leaf extracts. Pharmacogn. Res. 2015, 7, 23–31.
  13. Heryanto, R.; Pradono, D.I.; Marlina, E.; Darusman, L.K. Classification of java tea (Orthosiphon aristatus) quality using FTIR spectroscopy and chemometrics. In International Symposium on Bioinformatics, Chemometrics and Metabolomics; Kusuma, W.A., Rohman, A., Putri, S.P., Eds.; Iop Publishing Ltd.: Bristol, UK, 2017; Volume 835.
  14. Febriani, Y.; Fidrianny, I.; Elfahmi. Isolation of two methoxy flavonoid compounds from kumis kucing (Orthoshipon stamineus, Benth.) a popular plant in Indonesian herbal medicine Jamu. Res. J. Pharm. Biol. Chem. Sci. 2017, 8, 1640–1646.
  15. Li, Y.M.; Xiang, B.; Li, X.Z.; Yan, Y.M.; Cheng, Y.X. New Diterpenoids from Clerodendranthus spicatus. Nat. Prod. Bioprospect. 2017, 7, 263–267.
  16. Ma, G.X.; Zhang, X.P.; Li, P.F.; Sun, Z.H.; Zhu, N.L.; Zhu, Y.D.; Yang, J.S.; Chen, D.L.; Wu, H.F.; Xu, X.D. Four new phenolic acid with unusual bicycle octane moiety from Clerodendranthus spicatus and their anti-inflammatory activity. Fitoterapia 2015, 105, 61–65.
  17. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2014, 37 (Suppl. S1), 81–90.
  18. Federation, I.D. IDF Diabetes Atlas, 10th ed.; International Diabetes Federation: Brussels, Belgium, 2021.
  19. Prabhakar, P.K.; Doble, M. Mechanism of action of natural products used in the treatment of diabetes mellitus. Chin. J. Integr Med. 2011, 17, 563–574.
  20. Choudhury, H.; Pandey, M.; Hua, C.K.; Mun, C.S.; Jing, J.K.; Kong, L.; Ern, L.Y.; Ashraf, N.A.; Kit, S.W.; Yee, T.S.; et al. An update on natural compounds in the remedy of diabetes mellitus: A systematic review. J. Tradit. Complement. Med. 2018, 8, 361–376.
  21. Xu, L.; Li, Y.; Dai, Y.; Peng, J. Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms. Pharm. Res. 2018, 130, 451–465.
  22. Wehmeier, U.F.; Piepersberg, W. Biotechnology and molecular biology of the alpha-glucosidase inhibitor acarbose. Appl. Microbiol. Biotechnol. 2004, 63, 613–625.
  23. Furman, B.L. The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent. Toxicon 2012, 59, 464–471.
  24. Fu, Y. Historical story on natural medicinal chemistry: 60 years history of metformin, a classical antidiabetic drug originated from Galega officinalis. Chin. Tradit. Herbal Drugs 2017, 48, 4591–4600.
  25. Wang, S.; Lu, A.; Zhang, L.; Shen, M.; Xu, T.; Zhan, W.; Jin, H.; Zhang, Y.; Wang, W. Extraction and purification of pumpkin polysaccharides and their hypoglycemic effect. Int. J. Biol. Macromol. 2017, 98, 182–187.
  26. Zhao, R.; Jin, R.; Chen, Y.; Han, F.-M. Hypoglycemic and Hypolipidemic Effects of Lycium barbarum Polysaccharide in Diabetic Rats. Chin. Herb. Med. 2015, 7, 310–315.
  27. Bai, Y.; Zang, X.; Ma, J.; Xu, G. Anti-Diabetic Effect of Portulaca oleracea L. Polysaccharideandits Mechanism in Diabetic Rats. Int. J. Mol. Sci. 2016, 17, 1201.
  28. Shori, A.B. Screening of antidiabetic and antioxidant activities of medicinal plants. J. Integr. Med. 2015, 13, 297–305.
  29. Umeno, A.; Horie, M.; Murotomi, K.; Nakajima, Y.; Yoshida, Y. Antioxidative and Antidiabetic Effects of Natural Polyphenols and Isoflavones. Molecules 2016, 21, 708.
  30. Batubara, I.; Komariah, K.; Sandrawati, A.; Nurcholis, W. Genotype selection for phytochemical content and pharmacological activities in ethanol extracts of fifteen types of Orthosiphon aristatus (Blume) Miq. leaves using chemometric analysis. Sci. Rep. 2020, 10, 20945.
  31. Lau, C.H.; Chua, L.S. Solvation Free Energy Simulation for Rosmarinic Acid Extraction from Orthosiphon stamineus. Methods Protoc. 2019, 2, 64.
  32. Lim, F.L.; Yam, M.F.; Asmawi, M.Z.; Chan, L.-K. Elicitation of Orthosiphon stamineus cell suspension culture for enhancement of phenolic compounds biosynthesis and antioxidant activity. Ind. Crops Prod. 2013, 50, 436–442.
  33. Chua, L.S.; Lau, C.H.; Chew, C.Y.; Ismail, N.I.M.; Soontorngun, N. Phytochemical profile of Orthosiphon aristatus extracts after storage: Rosmarinic acid and other caffeic acid derivatives. Phytomedicine 2018, 39, 49–55.
  34. Ismail, H.F.; Hashim, Z.; Soon, W.T.; Rahman, N.S.A.; Zainudin, A.N.; Majid, F.A.A. Comparative study of herbal plants on the phenolic and flavonoid content, antioxidant activities and toxicity on cells and zebrafish embryo. J. Tradit. Complement. Med. 2017, 7, 452–465.
  35. Deetae, P.; Parichanon, P.; Trakunleewatthana, P.; Chanseetis, C.; Lertsiri, S. Antioxidant and anti-glycation properties of Thai herbal teas in comparison with conventional teas. Food Chem. 2012, 133, 953–959.
  36. Akowuah, G.A.; Ismail, Z.; Norhayati, I.; Sadikun, A. The effects of different extraction solvents of varying polarities on polyphenols of Orthosiphon stamineus and evaluation of the free radical-scavenging activity. Food Chem. 2005, 93, 311–317.
  37. Seyedan, A.; Alshawsh, M.A.; Alshagga, M.A.; Mohamed, Z. Antiobesity and Lipid Lowering Effects of Orthosiphon stamineus in High-Fat Diet-Induced Obese Mice. Planta Med. 2017, 83, 684–692.
  38. Cai, X.; Xiao, C.; Xue, H.; Xiong, H.; Hang, Y.; Xu, J.; Lu, Y. A comparative study of the antioxidant and intestinal protective effects of extracts from different parts of Java tea (Orthosiphon stamineus). Food Sci. Nutr. 2018, 6, 579–584.
  39. Kothari, V.; Galdo, J.A.; Mathews, S.T. Hypoglycemic agents and potential anti-inflammatory activity. J. Inflamm. Res. 2016, 9, 27–38.
  40. Li, Z.; Geng, Y.N.; Jiang, J.D.; Kong, W.J. Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid Based Complement. Altern. Med. 2014, 2014, 1–12.
  41. Chen, W.-D.; Zhao, Y.-L.; Dai, Z.; Zhou, Z.-S.; Zhu, P.-F.; Liu, Y.-P.; Zhao, L.-X.; Luo, X.-D. Bioassay-guided isolation of anti-inflammatory diterpenoids with highly oxygenated substituents from kidney tea (Clerodendranthus spicatus). J. Food Biochem. 2020, 44, e13511.
  42. Awale, S.; Tezuka, Y.; Kobayashi, M.; Ueda, J.-Y.; Kadota, S. Neoorthosiphonone A; a nitric oxide (NO) inhibitory diterpene with new carbon skeleton from Orthosiphon stamineus. Tetrahedron Lett. 2004, 45, 1359–1362.
  43. Awale, S.; Tezuka, Y.; Banskota, A.H.; Kadota, S. Siphonols A–E: Novel nitric oxide inhibitors from Orthosiphon stamineus of Indonesia. Bioorg. Med. Chem. Lett. 2003, 13, 31–35.
  44. Jaiswal, M.; Schinske, A.; Pop-Busui, R. Lipids and lipid management in diabetes. Best Pr. Res. Clin. Endocrinol. Metab. 2014, 28, 325–338.
  45. Mosavat, M.; Mirsanjari, M.; Arabiat, D.; Smyth, A.; Whitehead, L. The Role of Sleep Curtailment on Leptin Levels in Obesity and Diabetes Mellitus. Obes. Facts 2021, 14, 214–221.
  46. Howlader, M.; Sultana, M.I.; Akter, F.; Hossain, M.M. Adiponectin gene polymorphisms associated with diabetes mellitus: A descriptive review. Heliyon 2021, 7, e07851.
  47. Lokman, E.F.; Saparuddin, F.; Muhammad, H.; Omar, M.H.; Zulkapli, A. Orthosiphon stamineus as a potential antidiabetic drug in maternal hyperglycemia in streptozotocin-induced diabetic rats. Integr. Med. Res. 2019, 8, 173–179.
  48. Sriplang, K.; Adisakwattana, S.; Rungsipipat, A.; Yibchok-anun, S. Effects of Orthosiphon stamineus aqueous extract on plasma glucose concentration and lipid profile in normal and streptozotocin-induced diabetic rats. J. Ethnopharmacol. 2007, 109, 510–514.
  49. Azam, A.A.; Pariyani, R.; Ismail, I.S.; Ismail, A.; Khatib, A.; Abas, F.; Shaari, K. Urinary metabolomics study on the protective role of Orthosiphon stamineus in Streptozotocin induced diabetes mellitus in rats via H-1 NMR spectroscopy. BMC Complement. Altern. Med. 2017, 17, 278.
  50. Xia, X.; Sun, B.; Li, W.; Zhang, X.; Zhao, Y. Anti-Diabetic Activity Phenolic Constituents from Red Wine Against α-Glucosidase and α-Amylase. J. Food Processing Preserv. 2017, 41, e12942.
  51. Yang, C.Y.; Yen, Y.Y.; Hung, K.C.; Hsu, S.W.; Lan, S.J.; Lin, H.C. Inhibitory effects of pu-erh tea on alpha glucosidase and alpha amylase: A systemic review. Nutr. Diabetes 2019, 9, 23.
  52. Zhu, C.; Niu, H.; Nie, A.; Bian, M. Bioactivity-guided separation of potential alpha-glycosidase inhibitor from clerodendranthus spicatus based on HSCCC coupled with molecular docking. Sci. Rep. 2021, 11, 6914.
  53. Luo, Y.; Liu, Y.; Wen, Q.; Feng, Y.; Tan, T. Comprehensive chemical and metabolic profiling of anti-hyperglycemic active fraction from Clerodendranthi Spicati Herba. J. Sep. Sci. 2021, 44, 1824–1832.
  54. Thengyai, S.; Thiantongin, P.; Sontimuang, C.; Ovatlarnporn, C.; Puttarak, P. α-Glucosidase and α-amylase inhibitory activities of medicinal plants in Thai antidiabetic recipes and bioactive compounds from Vitex glabrata R. Br. stem bark. J. Herb. Med. 2020, 19, 100302.
  55. Mohamed, E.A.H.; Siddiqui, M.J.A.; Ang, L.F.; Sadikun, A.; Chan, S.H.; Tan, S.C.; Asmawi, M.Z.; Yam, M.F. Potent alpha-glucosidase and alpha-amylase inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphon stamineus Benth as anti-diabetic mechanism. BMC Complement. Altern. Med. 2012, 12, 176.
  56. Schofield, C.J.; Sutherland, C. Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes. Diabet. Med. 2012, 29, 972–979.
  57. Huang, X.; Liu, G.; Guo, J.; Su, Z. The PI3K/AKT pathway in obesity and type 2 diabetes. Int. J. Biol. Sci. 2018, 14, 1483–1496.
  58. Schultze, S.M.; Hemmings, B.A.; Niessen, M.; Tschopp, O. PI3K/AKT, MAPK and AMPK signalling: Protein kinases in glucose homeostasis. Expert Rev. Mol. Med. 2012, 14, e1.
  59. Bakke, J.; Haj, F.G. Protein-tyrosine phosphatase 1B substrates and metabolic regulation. Semin. Cell Dev. Biol. 2015, 37, 58–65.
  60. Sharma, B.; Xie, L.; Yang, F.; Wang, W.; Zhou, Q.; Xiang, M.; Zhou, S.; Lv, W.; Jia, Y.; Pokhrel, L.; et al. Recent advance on PTP1B inhibitors and their biomedical applications. Eur. J. Med. Chem. 2020, 199, 112376.
  61. Phi Hung, N.; Huynh Nhu, T.; Duc Thuan, H.; Quoc Trung, V.; Minh Quan, P.; Manh Hung, T.; Dao Cuong, T. Glucose Uptake Stimulatory and PTP1B Inhibitory Activities of Pimarane Diterpenes from Orthosiphon stamineus Benth. Biomolecules 2019, 9, 859.
  62. Lee, H.-J.; Choi, Y.-J.; Park, S.-Y.; Kim, J.-Y.; Won, K.-C.; Son, J.-K.; Kim, Y.-W. Hexane Extract of Orthosiphon stamineus Induces Insulin Expression and Prevents Glucotoxicity in INS-1 Cells. Diabetes Metab. J. 2015, 39, 51–58.
  63. Stanford, K.I.; Goodyear, L.J. Exercise and type 2 diabetes: Molecular mechanisms regulating glucose uptake in skeletal muscle. Adv. Physiol. Educ. 2014, 38, 308–314.
  64. Mohamed, E.A.H.; Yam, M.F.; Ang, L.F.; Mohamed, A.J.; Asmawi, M.Z. Antidiabetic Properties and Mechanism of Action of Orthosiphon stamineus Benth Bioactive Sub-fraction in Streptozotocin-induced Diabetic Rats. J. Acupunct. Meridian Stud. 2013, 6, 31–40.
  65. Khattak, M.M.A.K.; Taher, M.; Ichwan, S.J.A.; Azahari, N. Selected Herbal Extracts Improve Diabetes Associated Factors in 3T3-L1 Adipocytes. Procedia—Soc. Behav. Sci. 2013, 91, 357–375.
  66. Azahari, N.; Khattak, M.M.A.K.; Taher, M.; Ichwan, S.J.A. Herbal extracts exhibit anti-diabetic activities in 3T3-L1 adipocytes model. Prog. Nutr. 2015, 17, 301–310.
  67. Hatting, M.; Tavares, C.D.J.; Sharabi, K.; Rines, A.K.; Puigserver, P. Insulin regulation of gluconeogenesis. Ann. N. Y. Acad. Sci. 2018, 1411, 21–35.
  68. Zhang, X.; Yang, S.; Chen, J.; Su, Z. Unraveling the Regulation of Hepatic Gluconeogenesis. Front. Endocrinol. 2018, 9, 802.
  69. Ostergaard, L.; Frandsen, C.S.; Madsbad, S. Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: A review. Expert Rev. Clin. Pharm. 2016, 9, 241–265.
  70. Parsamanesh, N.; Moossavi, M.; Bahrami, A.; Butler, A.E.; Sahebkar, A. Therapeutic potential of curcumin in diabetic complications. Pharm. Res. 2018, 136, 181–193.
  71. Liu, G.J.; Huang, R.G.; Zheng, X.Z.; Chen, J.H.; Li, Y.T. Study on the protective effect of Kidney tea on kidney of diabetic rats and its mechanism. Chin. J. Integr. Tradit. West. Nephrol. 2007, 8, 32–34.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Integrative & Complementary Medicine
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Haixia Chen
View Times: 534
Revisions: 2 times (View History)
Update Date: 29 Mar 2022
Table of Contents
    1000/1000
    Hot Most Recent
    ScholarVision Creations
    Feedback